THROMBOPROPHYLAXIS

Clinical trials for THROMBOPROPHYLAXIS explained in plain language.

Never miss a new study

Get alerted when new THROMBOPROPHYLAXIS trials appear

Sign up with your email to follow new studies for THROMBOPROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Completed 1

Daily pill vs. daily shot: race to stop deadly clots in broken legs

Prevention Recruiting now

This study is testing if a daily pill (rivaroxaban) works as well as or better than daily injections (LMWH) at preventing dangerous blood clots in people with serious leg injuries who need a cast or brace. It focuses on patients identified as high-risk for clots. Researchers will…

Matched conditions: THROMBOPROPHYLAXIS

Phase: PHASE3 • Sponsor: University Hospital, Angers • Aim: Prevention

Last updated Mar 30, 2026 14:32 UTC

THROMBOPROPHYLAXIS

Get alerted when new THROMBOPROPHYLAXIS trials appear

Daily pill vs. daily shot: race to stop deadly clots in broken legs